Nuzenio

Hypertension Drug Trial

Hypertension Drug Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

TNX-103 misses primary endpoint in phase 3 LEVEL PH-HFpEF trial - HCPLiveHCPLive · Mon, 10 Aug 2026 14:36:46 GMTTenax trounced by phase 3 heart failure readout - pharmaphorumpharmaphorum · Mon, 10 Aug 2026 14:13:28 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - STATSTAT · Mon, 10 Aug 2026 11:43:53 GMTOrion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:58 GMTNew Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win - MedPage TodayMedPage Today · Fri, 31 Jul 2026 07:00:00 GMTJiangsu Hengrui Pharmaceuticals Gets China Nod for Hypertension Drug Trial - MoomooMoomoo · Tue, 28 Jul 2026 01:45:39 GMT

Timeline

Mon, 10 Aug 2026 14:36:46 GMTTNX-103 misses primary endpoint in phase 3 LEVEL PH-HFpEF trial - HCPLive
Mon, 10 Aug 2026 14:13:28 GMTTenax trounced by phase 3 heart failure readout - pharmaphorum
Mon, 10 Aug 2026 11:43:53 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - STAT
Mon, 10 Aug 2026 11:19:58 GMTOrion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint - The Manila Times
Fri, 31 Jul 2026 07:00:00 GMTNew Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win - MedPage Today
Tue, 28 Jul 2026 01:45:39 GMTJiangsu Hengrui Pharmaceuticals Gets China Nod for Hypertension Drug Trial - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Hypertension Drug Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.